Scott Daniel Cormack
Directeur/Membre du Conseil chez PC-TRiADD
Postes actifs de Scott Daniel Cormack
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
PC-TRiADD
 PC-TRiADD Miscellaneous Commercial ServicesCommercial Services PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | - | - |
| Vancouver General Hospital | Corporate Officer/Principal | - | - |
Novelogics Biotechnology, Inc.
 Novelogics Biotechnology, Inc. BiotechnologyHealth Technology Novelogics Biotechnology, Inc. is a pre-clinical stage biotech company based in Vancouver, Canada, that is developing innovative antibody immunotherapies for cancer using a novel "interceptor" approach. Novelogics aims to revolutionize cancer treatment with its innovative solution that acts as an "interceptor" of unattached immunosuppressive proteins that have the capacity to shut down critical cancer-killing immune cells. The Canadian company is seeking staged investments and/or partnerships to advance its program. The company was founded by Wayne Cheney and Elaine Allison, with Allison serving as CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Scott Daniel Cormack
Anciens postes connus de Scott Daniel Cormack
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 01/08/2008 | 11/05/2021 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Directeur/Membre du Conseil | 01/05/2000 | 01/08/2017 |
| Directeur Général | 01/08/2008 | 01/08/2017 | |
| Directeur Financier/CFO | 01/05/2000 | 11/08/2014 | |
| Fondateur | 01/10/1991 | 01/08/2017 | |
| President | 01/08/2008 | 01/08/2017 | |
| Secrétaire Général | 01/05/2000 | 01/08/2017 | |
| Treasurer | 01/05/2000 | 01/08/2017 | |
| AURINIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/01/2012 | 01/01/2014 |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 02/10/2008 | 02/10/2008 |
OncoGenex Technologies, Inc.
 OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Directeur Général | 01/05/2000 | 22/08/2008 |
| Fondateur | 22/08/2008 | 22/08/2008 | |
| President | - | 22/08/2008 | |
| Milestone Medica Corp. | Corporate Officer/Principal | 02/01/2001 | 02/01/2001 |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░ ░░░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Scott Daniel Cormack
| University of Alberta | Undergraduate Degree |
Statistiques
Internationale
| Canada | 13 |
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 7 |
| President | 4 |
| Chief Executive Officer | 3 |
Sectorielle
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Technology |
| Milestone Medica Corp. | Finance |
| NeuroSpheres Ltd. | |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
| Salpep Biotechnology, Inc. | |
| Vetrepharm, Inc. | |
| For Tomorrow | |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
PC-TRiADD
PC-TRiADD Miscellaneous Commercial ServicesCommercial Services PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada. | Commercial Services |
| Vancouver General Hospital | |
Fe Pharmaceuticals (Canada), Inc.
 Fe Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Fe Pharmaceuticals (Canada), Inc. operates as a research institution. It offers indication & treatment challenge, technical innovation and market services. The company was founded by William M. Cheliak and Bruce Holbein and is headquartered in Halifax, Canada. | Health Technology |
Novelogics Biotechnology, Inc.
Novelogics Biotechnology, Inc. BiotechnologyHealth Technology Novelogics Biotechnology, Inc. is a pre-clinical stage biotech company based in Vancouver, Canada, that is developing innovative antibody immunotherapies for cancer using a novel "interceptor" approach. Novelogics aims to revolutionize cancer treatment with its innovative solution that acts as an "interceptor" of unattached immunosuppressive proteins that have the capacity to shut down critical cancer-killing immune cells. The Canadian company is seeking staged investments and/or partnerships to advance its program. The company was founded by Wayne Cheney and Elaine Allison, with Allison serving as CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Scott Daniel Cormack
- Expérience
